NWSA
60
2
EXR
35
7
ADSK
45
-5
AN
50
3
HBI
21
3
TRV
56
-5
AON
34
4
PEP
72
16
DOW
43
-4
PCAR
59
-2
PGR
77
4
CI
52
-7
OMC
61
6
DO
62
-7
PRU
40
-2
CRM
44
2
SLG
71
5
FLS
53
-2
NEE
42
4
RIG
41
-3
NWSA
60
2
EXR
35
7
ADSK
45
-5
AN
50
3
HBI
21
3
TRV
56
-5
AON
34
4
PEP
72
16
DOW
43
-4
PCAR
59
-2
PGR
77
4
CI
52
-7
OMC
61
6
DO
62
-7
PRU
40
-2
CRM
44
2
SLG
71
5
FLS
53
-2
NEE
42
4
RIG
41
-3
Financhill
Back

Akoya Biosciences 10K Form

Sell
13

AKYA
Akoya Biosciences

Last Price:
3.85
Seasonality Move:
14.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AKYA News And Ratings

See the #1 stock for the next 7 days that we like better than AKYA

AKYA Financial Statistics

Sales & Book Value

Annual Sales: $96.63M
Cash Flow: $-6.18M
Price / Cash Flow: 0
Annual Sales: $1.09
Price / Book: 3.6

Profitability

EPS (TTM): -1.46000
Net Income (TTM): $-63.32M
Gross Margin: $56.31M
Return on Equity: -109.8%
Return on Assets: -36.11%

Akoya Biosciences Earnings Forecast

Key Akoya Biosciences Financial Ratios

  • The Gross Profit Margin over the past 5 years for AKYA is 58.27%.
  • The Selling, General & Administrative Expenses for AKYA have been equal to 85.25% of Gross Profit Margin.
  • The Research & Development expenses have been 22.65% of Revenue.
  • The Interest Expense is -13.84% of Operating Income.
  • The Net Earning history of AKYA is -65.53% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

Akoya Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: AKYA
Website: akoyabio.com

Debt

Debt-to-Equity Ratio: 1.4
Current Ratio: 3.45
Quick Ratio: 2.83

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AKYA Technical Analysis vs Fundamental Analysis

Sell
13
Akoya Biosciences (AKYA) is a Sell

Is Akoya Biosciences a Buy or a Sell?

  • Akoya Biosciences stock is rated a Sell
    The current Akoya Biosciences [AKYA] share price is $3.91. The Score for AKYA is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.